Human CD4+CD25+CD226- Tregs Demonstrate Increased Purity, Lineage Stability, and Suppressive Capacity Versus CD4+CD25+CD127lo/- Tregs for Adoptive Cell Therapy is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: T32 DK108736, R01 DK106191, UG3/UH3 DK122638, P01 AI042288
National Institutes of Health
Grant: 5R01DK106191-02
The CD226 and TIGIT Costimulatory Axis in Type 1 Diabetes
National Institutes of Health
Grant: 3T32DK108736-02S1
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering
National Institutes of Health
Grant: 5UH3DK122638-05
Engineering a Human Microphysiological System for the Characterization of Islet-Immune Interactions
National Institutes of Health
Grant: 5P01AI042288-17
Administrative Core
Fields of Study
Keywords
Sustainable Development Goals